Management of allergy to penicillins and other beta-lactams
Research article published in Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2015)
Abstract
The Standards of Care Committee of the British Society for Allergy and Clinical Immunology (BSACI) and an expert panel have prepared this guidance for the management of immediate and non-immediate allergic reactions to penicillins and other beta-lactams. The guideline is intended for UK specialists in both adult and paediatric allergy and for other clinicians practising allergy in secondary and tertiary care. The recommendations are evidence based, but where evidence is lacking, the panel reached consensus. During the development of the guideline, all BSACI members were consulted using a Web-based process and all comments carefully considered. Included in the guideline are epidemiology of allergic reactions to beta-lactams, molecular structure, formulations available in the UK and a description of known beta-lactam antigenic determinants. Sections on the value and limitations of clinical history, skin testing and laboratory investigations for both penicillins and cephalosporins are included. Cross-reactivity between penicillins and cephalosporins is discussed in detail. Recommendations on oral provocation and desensitization procedures have been made. Guidance for beta-lactam allergy in children is given in a separate section. An algorithm to help the clinician in the diagnosis of patients with a history of penicillin allergy has also been included.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Zusammenfassung
The Standards of Care Committee of the British Society for Allergy and Clinical Immunology (BSACI) and an expert panel have prepared this guidance for the management of immediate and non-immediate allergic reactions to penicillins and other beta-lactams.
Warum dies für die Hirudotherapie relevant ist
Diese Praxisleitlinie der Britischen Gesellschaft für Allergie und Klinische Immunologie liefert evidenzbasierte Empfehlungen und Konsensstatements zum Management sofortiger und verzögerter allergischer Reaktionen auf Penicilline und andere Betalaktame, einschließlich Epidemiologie, Hauttestung, oraler Provokation, Desensibilisierung und pädiatrischer Leitlinien. Im Abstract findet sich kein Inhalt zu Blutegeln, Hirudotherapie, Hirudin oder dem Blutegel-Sekretom. Der Artikel befasst sich ausschließlich mit dem Management antimikrobieller Allergien. Daher hat dieser Artikel keine erkennbare Relevanz für das ASH-Gebiet der Hirudotherapie oder aus Blutegeln gewonnener Therapeutika.
Zitation
Management of allergy to penicillins and other beta-lactams
Mirakian R et al. · Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2015
Verwandter klinischer Kontext
Erfahren Sie, wie diese Forschung mit der klinischen Praxis verknüpft ist
Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: 18. Juni 2026